To The Moon

In the rollercoaster world of investments, finding stocks with high insider ownership and robust earnings growth is a bit like striking gold. Insider ownership signals confidence from those in the know, while earnings growth hints at a company’s future profitability. Let’s dive into three promising Chinese stocks: Teyi Pharmaceutical Group Ltd, Suzhou Shijing Environmental Technology Ltd, and Ningbo Sunrise Elc Technology Ltd. With significant insider ownership and impressive earnings growth, these companies are worth a closer look. Spotting Top Chinese Stocks for Future Growth Teyi Pharmaceutical: Betting Big on Traditional Medicine Insider Ownership: 39.2% Earnings Growth Forecast: 41.1% annually Market Capitalisation: CN¥4.07 billion P/E Ratio: 13.6x (2024), 10.7x (2025) P/B Ratio: 1.83

Investing in Verizon Communications could be a wise move for those seeking stable dividend income and long-term growth. Here’s a deep dive into why $Verizon(VZ)$ might be a great addition to your investment portfolio. Harnessing the Cloud: Verizon's Tech Investments Drive Future Growth Recent Performance and Financial Metrics Verizon's Q2 2024 earnings report shows a mixed but stable performance. The company reported total operating revenue of $32.8 billion, reflecting a slight year-over-year growth of 0.6%. Although net income saw a minor decline, the adjusted earnings per share (EPS) stood at $1.15, demonstrating resilience amid challenging market conditions. Earnings and Revenue (Estimated and Reported) Q3 2022 - Q3 2024 Valuation-wise, Verizon'

When it comes to investing in 2024, Eli Lilly and Company (LLY) and the Vanguard S&P 500 ETF (VOO) present two very different avenues, each with its own set of benefits and risks. With LLY’s earnings report just around the corner on 8 August, it’s a perfect time to weigh up these two intriguing investment options. Strategising with precision: The art of forecasting stock market trends Eli Lilly’s Explosive Growth: Worth the Hype? Eli Lilly has had a stellar year so far, delivering a staggering 62.09% return year-to-date. This phenomenal performance can be largely credited to the soaring popularity of its weight loss medications, Mounjaro and Zepbound. With the pharmaceutical industry constantly evolving, LLY’s Q2 2024 revenue projection of $9.97 billion marks a hefty 20% increase from

The SPDR S&P Bank ETF (KBE) has been making waves—like a financial tidal wave—with its scorching performance. Over the past month, KBE has soared by an impressive 17.9%, leaving the broader market and tech-centric ETFs in the dust. Let’s dive into what’s driving this surge, scrutinise its financials, and ponder whether it's the right time to jump on the KBE bandwagon. Modern ETF Investment: Technology Driving Global Financial Markets Recent Performance and Financial Metrics KBE's recent performance has been nothing short of spectacular—like watching your favourite football team win the championship while your other investments sit on the bench. As of July 29, 2024, the ETF has rocketed 17.9% over the past month, while the S&P 500 stayed flat, and the tech-heavy Invesco QQQ Trust (

The Paris 2024 Olympics is set to be a grand global spectacle, captivating sports enthusiasts and investors alike. As the world's attention converges on the City of Lights, the event presents a unique opportunity for economic growth and potential investment gains. Paris 2024 Olympics: a vibrant and energetic celebration Thrills, Spills, and New Skills The Paris Olympics promises a thrilling showcase of athleticism and diversity. From the traditional allure of track and field to the exhilarating rush of kayaking, the event caters to a wide range of sports enthusiasts. The inclusion of newer sports like skateboarding and sport climbing adds a contemporary edge to the Games, attracting a younger demographic. Key events I’ll be watching include: Athletics: Spanning from August 1 to August 11,

Salesforce has recently been catching my eye, and for good reason. Their recent performance and future prospects have me intrigued, especially after their robust Q1 fiscal 2025 results. Let's dive into the numbers and see what makes Salesforce a potential gem in the tech sector. AI: Driving Salesforce's Innovation Stellar Q1 Fiscal 2025 Results In May 2024, $Salesforce.com(CRM)$ announced its Q1 fiscal 2025 results, and they were nothing short of impressive. The company reported a total revenue of $9.13 billion, marking an 11% increase year-over-year. More astonishing was the GAAP operating margin, which soared to 18.7%, a massive leap of 1,370 basis points from the previous year. This substantial improvement underscores Salesforce's dedication to

As we inch closer to AMD's earnings report on Tuesday, July 30, the big question is: can AMD's stock finally break through the elusive $200 barrier? With a stellar performance in the first quarter of 2024 and optimistic forecasts, $Advanced Micro Devices(AMD)$ is looking like a tantalising investment opportunity. Let’s dive into the company’s recent financial feats, current stock metrics, and future prospects to see if now’s the time to hop on the AMD bandwagon. AMD: Pioneering Future Technology Recent Financial Performance: A Mixed Bag with a Silver Lining AMD’s first-quarter results for 2024 were quite the showstopper. Revenue nudged up by 2% year-over-year to a cool $5.5 billion, just a smidge above analysts’ expectations. Adjusted earnings per

As earnings season rolls around, the spotlight is on pharmaceutical titans AbbVie and AstraZeneca, both set to report on Thursday, 25 July 2024. With keen interest from investors, let's delve into the financial metrics, recent performances, and future prospects of these two heavyweights to see which one stands out as the better investment. Cutting-edge research driving pharmaceutical advancements A Look at AbbVie's Financial Health AbbVie's Q1 2024 results painted an optimistic picture despite some challenges. The company posted a GAAP diluted EPS of $0.77, marking a massive 492.3% year-over-year increase, while the adjusted diluted EPS hit $2.31, surpassing analyst expectations of $2.23. However, this was a 6.1% decline from the previous year. Net revenues stood at $12.31 billion, a mode

As earnings reports for Amazon and $Spotify Technology S.A.(SPOT)$ loom on the horizon, it's time to analyse which of these tech titans offers the better investment opportunity. With Amazon set to release its earnings soon and Spotify’s Q2 2024 report expected on Tuesday, July 23, let's dissect their financials, performance, and future prospects. Financial Performance and Metrics Amazon: A Tech Behemoth on the Rise Amazon’s Q1 2024 results were nothing short of impressive. The company reported revenue of $143.3 billion, up 13% year-over-year, despite a 16% quarter-over-quarter decline due to seasonal factors. $Amazon.com(AMZN)$ surpassed Wall Street estimates by approximately $764 million, showcasing its

Both Microsoft and Alphabet are set to release their earnings reports on Tuesday, 23 July, and they’ve both shown impressive resilience and growth in 2024. However, there are nuanced differences that investors should consider before diving in. Immersed in a futuristic digital world Year-to-Date Performance: A Head-to-Head Comparison Since Q1, both $Microsoft(MSFT)$ and Alphabet have demonstrated impressive performances. Microsoft's share price has climbed approximately 36% year-to-date, and Alphabet has matched this growth with a similar 36% increase. This parallel performance underscores robust investor confidence, particularly in their AI initiatives. MSFT vs GOOGL: 1-year performance Financial Fortitude: Who's Winning the Numbers Game? Microsof